Trial NCT04102436

View at ClinicalTrials.gov 
Org. Study IDs: 190143
Secondary IDs: 19-C-0143

Last trial update was posted on 2024-03-12

MeSH Interventions

Aldesleukin Cyclophosphamide Fludarabine

MeSH Conditions

Urogenital Neoplasms

Other Conditions

Breast Cancer Endocrine/Neuroendocrine Gastrointestinal/Genitourinary Cancers Non-Small Cell Lung Cancer Ovarian Cancer

Stopping Reasons

Difficulty with availability of GLP-grade reagents for manufacturing.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID